Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 49 entries
Sorted by: Best Match Show Resources per page
Formulation and bioequivalence of two valsartan tablets after a single oral administration.

Scientia pharmaceutica

Zaid AN, Cortesi R, Qaddomi A, Khammash S.
PMID: 21617777
Sci Pharm. 2011 Jan-Mar;79(1):123-35. doi: 10.3797/scipharm.1009-01. Epub 2010 Nov 20.

The aim of this study is to assess the quality of Valzan(®) tablet (160 mg, valsartan immediate release test formulation) by comparing its pharmacokinetic parameters with Diovan(®) tablet (160 mg, valsartan reference formulation). Valzan(®) tablets were prepared according to...

Cite
Zaid AN, Cortesi R, Qaddomi A, et al. Formulation and bioequivalence of two valsartan tablets after a single oral administration. Sci Pharm. 2010;79(1):123-35doi: 10.3797/scipharm.1009-01.
Zaid, A. N., Cortesi, R., Qaddomi, A., & Khammash, S. (2011). Formulation and bioequivalence of two valsartan tablets after a single oral administration. Scientia pharmaceutica, 79(1), 123-35. https://doi.org/10.3797/scipharm.1009-01
Zaid, Abdel Naser, et al. "Formulation and bioequivalence of two valsartan tablets after a single oral administration." Scientia pharmaceutica vol. 79,1 (2011): 123-35. doi: https://doi.org/10.3797/scipharm.1009-01
Zaid AN, Cortesi R, Qaddomi A, Khammash S. Formulation and bioequivalence of two valsartan tablets after a single oral administration. Sci Pharm. 2011 Jan-Mar;79(1):123-35. doi: 10.3797/scipharm.1009-01. Epub 2010 Nov 20. PMID: 21617777; PMCID: PMC3097505.
Copy Download .nbib Format: NLM
Global Access to Essential Medicines for Childhood Cancer: A Cross-Sectional Survey.

Journal of global oncology

Cohen P, Friedrich P, Lam C, Jeha S, Metzger ML, Qaddoumi I, Naidu P, Faughnan L, Rodriguez-Galindo C, Bhakta N.
PMID: 30582430
J Glob Oncol. 2018 Dec;4:1-11. doi: 10.1200/JGO.18.00150.

PURPOSE: Global data mapping access to essential chemotherapeutics for pediatric cancer are scarce. We report a survey of international pediatric cancer care providers' access to these medicines.METHODS: A Web-based survey was sent to pediatric oncologists registered on the Cure4Kids...

Cite
Cohen P, Friedrich P, Lam C, et al. Global Access to Essential Medicines for Childhood Cancer: A Cross-Sectional Survey. J Glob Oncol. 2018;4:1-11doi: 10.1200/JGO.18.00150.
Cohen, P., Friedrich, P., Lam, C., Jeha, S., Metzger, M. L., Qaddoumi, I., Naidu, P., Faughnan, L., Rodriguez-Galindo, C., & Bhakta, N. (2018). Global Access to Essential Medicines for Childhood Cancer: A Cross-Sectional Survey. Journal of global oncology, 41-11. https://doi.org/10.1200/JGO.18.00150
Cohen, Phillip, et al. "Global Access to Essential Medicines for Childhood Cancer: A Cross-Sectional Survey." Journal of global oncology vol. 4 (2018): 1-11. doi: https://doi.org/10.1200/JGO.18.00150
Cohen P, Friedrich P, Lam C, Jeha S, Metzger ML, Qaddoumi I, Naidu P, Faughnan L, Rodriguez-Galindo C, Bhakta N. Global Access to Essential Medicines for Childhood Cancer: A Cross-Sectional Survey. J Glob Oncol. 2018 Dec;4:1-11. doi: 10.1200/JGO.18.00150. PMID: 30582430; PMCID: PMC7010437.
Copy Download .nbib Format: NLM
Spontaneous .

ACS pharmacology & translational science

Darakjian LI, Rigakou A, Brannen A, Qusa MH, Tasiakou N, Diamantakos P, Reed MN, Panizzi P, Boersma MD, Melliou E, El Sayed KA, Magiatis P, Kaddoumi A.
PMID: 33615171
ACS Pharmacol Transl Sci. 2021 Jan 05;4(1):179-192. doi: 10.1021/acsptsci.0c00166. eCollection 2021 Feb 12.

Since the first discovery of its ibuprofen-like anti-inflammatory activity in 2005, the olive phenolic (-)-oleocanthal gained great scientific interest and popularity due to its reported health benefits. (-)-Oleocanthal is a monophenolic secoiridoid exclusively occurring in extra-virgin olive oil (EVOO)....

Cite
Darakjian LI, Rigakou A, Brannen A, et al. Spontaneous . ACS Pharmacol Transl Sci. 2021;4(1):179-192doi: 10.1021/acsptsci.0c00166.
Darakjian, L. I., Rigakou, A., Brannen, A., Qusa, M. H., Tasiakou, N., Diamantakos, P., Reed, M. N., Panizzi, P., Boersma, M. D., Melliou, E., El Sayed, K. A., Magiatis, P., & Kaddoumi, A. (2021). Spontaneous . ACS pharmacology & translational science, 4(1), 179-192. https://doi.org/10.1021/acsptsci.0c00166
Darakjian, Lucy I, et al. "Spontaneous ." ACS pharmacology & translational science vol. 4,1 (2021): 179-192. doi: https://doi.org/10.1021/acsptsci.0c00166
Darakjian LI, Rigakou A, Brannen A, Qusa MH, Tasiakou N, Diamantakos P, Reed MN, Panizzi P, Boersma MD, Melliou E, El Sayed KA, Magiatis P, Kaddoumi A. Spontaneous . ACS Pharmacol Transl Sci. 2021 Jan 05;4(1):179-192. doi: 10.1021/acsptsci.0c00166. eCollection 2021 Feb 12. PMID: 33615171; PMCID: PMC7887843.
Copy Download .nbib Format: NLM
Changes in the clinical phenotype and behavior of pediatric luminal Crohn's disease at diagnosis in the last decade.

Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver

Sassine S, Savoie Robichaud M, Lin YF, Djani L, Cambron-Asselin C, Qaddouri M, Zekhnine S, Grzywacz K, Groleau V, Dirks M, Drouin É, Halac U, Marchand V, Girard C, Courbette O, Patey N, Dal Soglio D, Deslandres C, Jantchou P.
PMID: 34756526
Dig Liver Dis. 2021 Oct 27; doi: 10.1016/j.dld.2021.09.012. Epub 2021 Oct 27.

BACKGROUND AND AIMS: The aims of this study were to describe the trends in the behavior of pediatric CD during the last decade and to describe the seasonal variation of disease presentation.METHODS: Patients under 18 years old and diagnosed...

Cite
Sassine S, Savoie Robichaud M, Lin YF, et al. Changes in the clinical phenotype and behavior of pediatric luminal Crohn's disease at diagnosis in the last decade. Dig Liver Dis. 2021;doi: 10.1016/j.dld.2021.09.012.
Sassine, S., Savoie Robichaud, M., Lin, Y. F., Djani, L., Cambron-Asselin, C., Qaddouri, M., Zekhnine, S., Grzywacz, K., Groleau, V., Dirks, M., Drouin, �. �., Halac, U., Marchand, V., Girard, C., Courbette, O., Patey, N., Dal Soglio, D., Deslandres, C., & Jantchou, P. (2021). Changes in the clinical phenotype and behavior of pediatric luminal Crohn's disease at diagnosis in the last decade. Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver, . https://doi.org/10.1016/j.dld.2021.09.012
Sassine, Samuel, et al. "Changes in the clinical phenotype and behavior of pediatric luminal Crohn's disease at diagnosis in the last decade." Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver vol. (2021). doi: https://doi.org/10.1016/j.dld.2021.09.012
Sassine S, Savoie Robichaud M, Lin YF, Djani L, Cambron-Asselin C, Qaddouri M, Zekhnine S, Grzywacz K, Groleau V, Dirks M, Drouin É, Halac U, Marchand V, Girard C, Courbette O, Patey N, Dal Soglio D, Deslandres C, Jantchou P. Changes in the clinical phenotype and behavior of pediatric luminal Crohn's disease at diagnosis in the last decade. Dig Liver Dis. 2021 Oct 27; doi: 10.1016/j.dld.2021.09.012. Epub 2021 Oct 27. PMID: 34756526.
Copy Download .nbib Format: NLM
Spontaneous .

ACS pharmacology & translational science

Darakjian LI, Rigakou A, Brannen A, Qusa MH, Tasiakou N, Diamantakos P, Reed MN, Panizzi P, Boersma MD, Melliou E, El Sayed KA, Magiatis P, Kaddoumi A.
PMID: 33615171
ACS Pharmacol Transl Sci. 2021 Jan 05;4(1):179-192. doi: 10.1021/acsptsci.0c00166. eCollection 2021 Feb 12.

Since the first discovery of its ibuprofen-like anti-inflammatory activity in 2005, the olive phenolic (-)-oleocanthal gained great scientific interest and popularity due to its reported health benefits. (-)-Oleocanthal is a monophenolic secoiridoid exclusively occurring in extra-virgin olive oil (EVOO)....

Cite
Darakjian LI, Rigakou A, Brannen A, et al. Spontaneous . ACS Pharmacol Transl Sci. 2021;4(1):179-192doi: 10.1021/acsptsci.0c00166.
Darakjian, L. I., Rigakou, A., Brannen, A., Qusa, M. H., Tasiakou, N., Diamantakos, P., Reed, M. N., Panizzi, P., Boersma, M. D., Melliou, E., El Sayed, K. A., Magiatis, P., & Kaddoumi, A. (2021). Spontaneous . ACS pharmacology & translational science, 4(1), 179-192. https://doi.org/10.1021/acsptsci.0c00166
Darakjian, Lucy I, et al. "Spontaneous ." ACS pharmacology & translational science vol. 4,1 (2021): 179-192. doi: https://doi.org/10.1021/acsptsci.0c00166
Darakjian LI, Rigakou A, Brannen A, Qusa MH, Tasiakou N, Diamantakos P, Reed MN, Panizzi P, Boersma MD, Melliou E, El Sayed KA, Magiatis P, Kaddoumi A. Spontaneous . ACS Pharmacol Transl Sci. 2021 Jan 05;4(1):179-192. doi: 10.1021/acsptsci.0c00166. eCollection 2021 Feb 12. PMID: 33615171; PMCID: PMC7887843.
Copy Download .nbib Format: NLM
Cancer care for children in the Gaza Strip.

The Lancet. Oncology

Salman Z, Shbair M, Zeineddin M, Balousha T, Qaddoumi I, Rodriguez-Galindo C.
PMID: 34856140
Lancet Oncol. 2021 Dec;22(12):1667-1668. doi: 10.1016/S1470-2045(21)00655-0.

No abstract available.

Cite
Salman Z, Shbair M, Zeineddin M, et al. Cancer care for children in the Gaza Strip. Lancet Oncol. 2021;22(12):1667-1668doi: 10.1016/S1470-2045(21)00655-0.
Salman, Z., Shbair, M., Zeineddin, M., Balousha, T., Qaddoumi, I., & Rodriguez-Galindo, C. (2021). Cancer care for children in the Gaza Strip. The Lancet. Oncology, 22(12), 1667-1668. https://doi.org/10.1016/S1470-2045(21)00655-0
Salman, Zeena, et al. "Cancer care for children in the Gaza Strip." The Lancet. Oncology vol. 22,12 (2021): 1667-1668. doi: https://doi.org/10.1016/S1470-2045(21)00655-0
Salman Z, Shbair M, Zeineddin M, Balousha T, Qaddoumi I, Rodriguez-Galindo C. Cancer care for children in the Gaza Strip. Lancet Oncol. 2021 Dec;22(12):1667-1668. doi: 10.1016/S1470-2045(21)00655-0. PMID: 34856140.
Copy Download .nbib Format: NLM
Factors associated with time to clinical remission in pediatric luminal Crohn's disease: A retrospective cohort study.

JGH open : an open access journal of gastroenterology and hepatology

Sassine S, Zekhnine S, Qaddouri M, Djani L, Cambron-Asselin C, Savoie-Robichaud M, Lin YF, Grzywacz K, Groleau V, Dirks M, Drouin É, Halac U, Marchand V, Girard C, Courbette O, Patey N, Dal Soglio D, Deslandres C, Jantchou P.
PMID: 34950781
JGH Open. 2021 Nov 27;5(12):1373-1381. doi: 10.1002/jgh3.12684. eCollection 2021 Dec.

BACKGROUND AND AIM: Data on factors influencing time to remission in pediatric Crohn's disease (CD) are very limited in the literature. The aim of this retrospective cohort study was to describe the trends of time to clinical remission over...

Cite
Sassine S, Zekhnine S, Qaddouri M, et al. Factors associated with time to clinical remission in pediatric luminal Crohn's disease: A retrospective cohort study. JGH Open. 2021;5(12):1373-1381doi: 10.1002/jgh3.12684.
Sassine, S., Zekhnine, S., Qaddouri, M., Djani, L., Cambron-Asselin, C., Savoie-Robichaud, M., Lin, Y. F., Grzywacz, K., Groleau, V., Dirks, M., Drouin, �. �., Halac, U., Marchand, V., Girard, C., Courbette, O., Patey, N., Dal Soglio, D., Deslandres, C., & Jantchou, P. (2021). Factors associated with time to clinical remission in pediatric luminal Crohn's disease: A retrospective cohort study. JGH open : an open access journal of gastroenterology and hepatology, 5(12), 1373-1381. https://doi.org/10.1002/jgh3.12684
Sassine, Samuel, et al. "Factors associated with time to clinical remission in pediatric luminal Crohn's disease: A retrospective cohort study." JGH open : an open access journal of gastroenterology and hepatology vol. 5,12 (2021): 1373-1381. doi: https://doi.org/10.1002/jgh3.12684
Sassine S, Zekhnine S, Qaddouri M, Djani L, Cambron-Asselin C, Savoie-Robichaud M, Lin YF, Grzywacz K, Groleau V, Dirks M, Drouin É, Halac U, Marchand V, Girard C, Courbette O, Patey N, Dal Soglio D, Deslandres C, Jantchou P. Factors associated with time to clinical remission in pediatric luminal Crohn's disease: A retrospective cohort study. JGH Open. 2021 Nov 27;5(12):1373-1381. doi: 10.1002/jgh3.12684. eCollection 2021 Dec. PMID: 34950781; PMCID: PMC8674552.
Copy Download .nbib Format: NLM
Follow-up evaluation of a web-based pediatric brain tumor board in Latin America.

Pediatric blood & cancer

Rosabal-Obando M, Osorio DS, Lassaletta A, La Madrid AM, Bartels U, Finlay JL, Qaddoumi I, Rutkowski S, Mynarek M.
PMID: 34003601
Pediatr Blood Cancer. 2021 Sep;68(9):e29073. doi: 10.1002/pbc.29073. Epub 2021 May 18.

BACKGROUND: Since 2013, pediatric oncologists from Central and South America discuss neuro-oncology cases with experts from North America and Europe in a web-based "Latin American Tumor Board" (LATB). Here, we evaluate the feasibility of recommendations rendered by the Board.METHODS:...

Cite
Rosabal-Obando M, Osorio DS, Lassaletta A, et al. Follow-up evaluation of a web-based pediatric brain tumor board in Latin America. Pediatr Blood Cancer. 2021;68(9):e29073doi: 10.1002/pbc.29073.
Rosabal-Obando, M., Osorio, D. S., Lassaletta, A., La Madrid, A. M., Bartels, U., Finlay, J. L., Qaddoumi, I., Rutkowski, S., & Mynarek, M. (2021). Follow-up evaluation of a web-based pediatric brain tumor board in Latin America. Pediatric blood & cancer, 68(9), e29073. https://doi.org/10.1002/pbc.29073
Rosabal-Obando, Mariel, et al. "Follow-up evaluation of a web-based pediatric brain tumor board in Latin America." Pediatric blood & cancer vol. 68,9 (2021): e29073. doi: https://doi.org/10.1002/pbc.29073
Rosabal-Obando M, Osorio DS, Lassaletta A, La Madrid AM, Bartels U, Finlay JL, Qaddoumi I, Rutkowski S, Mynarek M. Follow-up evaluation of a web-based pediatric brain tumor board in Latin America. Pediatr Blood Cancer. 2021 Sep;68(9):e29073. doi: 10.1002/pbc.29073. Epub 2021 May 18. PMID: 34003601.
Copy Download .nbib Format: NLM
Baseline Subfoveal Choroidal Thickness as a Predictor for Response to Short-Term Intravitreal Bevacizumab Injections in Diabetic Macular Edema.

Clinical ophthalmology (Auckland, N.Z.)

Dweikat A, Jarrar A, Akkawi M, Shehadeh M, Aghbar A, Qaddumi J, Akkawi M.
PMID: 34703204
Clin Ophthalmol. 2021 Oct 18;15:4175-4180. doi: 10.2147/OPTH.S325951. eCollection 2021.

PURPOSE: This article aims to evaluate how the subfoveal choroidal thickness (SFCT) and best-corrected visual acuity (BCVA) respond to the intravitreal injection of bevacizumab and to assess the correlation between these changes. It will also assess the use of...

Cite
Dweikat A, Jarrar A, Akkawi M, et al. Baseline Subfoveal Choroidal Thickness as a Predictor for Response to Short-Term Intravitreal Bevacizumab Injections in Diabetic Macular Edema. Clin Ophthalmol. 2021;15:4175-4180doi: 10.2147/OPTH.S325951.
Dweikat, A., Jarrar, A., Akkawi, M., Shehadeh, M., Aghbar, A., Qaddumi, J., & Akkawi, M. (2021). Baseline Subfoveal Choroidal Thickness as a Predictor for Response to Short-Term Intravitreal Bevacizumab Injections in Diabetic Macular Edema. Clinical ophthalmology (Auckland, N.Z.), 154175-4180. https://doi.org/10.2147/OPTH.S325951
Dweikat, Alaa, et al. "Baseline Subfoveal Choroidal Thickness as a Predictor for Response to Short-Term Intravitreal Bevacizumab Injections in Diabetic Macular Edema." Clinical ophthalmology (Auckland, N.Z.) vol. 15 (2021): 4175-4180. doi: https://doi.org/10.2147/OPTH.S325951
Dweikat A, Jarrar A, Akkawi M, Shehadeh M, Aghbar A, Qaddumi J, Akkawi M. Baseline Subfoveal Choroidal Thickness as a Predictor for Response to Short-Term Intravitreal Bevacizumab Injections in Diabetic Macular Edema. Clin Ophthalmol. 2021 Oct 18;15:4175-4180. doi: 10.2147/OPTH.S325951. eCollection 2021. PMID: 34703204; PMCID: PMC8536875.
Copy Download .nbib Format: NLM
Follow-up evaluation of a web-based pediatric brain tumor board in Latin America.

Pediatric blood & cancer

Rosabal-Obando M, Osorio DS, Lassaletta A, La Madrid AM, Bartels U, Finlay JL, Qaddoumi I, Rutkowski S, Mynarek M.
PMID: 34003601
Pediatr Blood Cancer. 2021 Sep;68(9):e29073. doi: 10.1002/pbc.29073. Epub 2021 May 18.

BACKGROUND: Since 2013, pediatric oncologists from Central and South America discuss neuro-oncology cases with experts from North America and Europe in a web-based "Latin American Tumor Board" (LATB). Here, we evaluate the feasibility of recommendations rendered by the Board.METHODS:...

Cite
Rosabal-Obando M, Osorio DS, Lassaletta A, et al. Follow-up evaluation of a web-based pediatric brain tumor board in Latin America. Pediatr Blood Cancer. 2021;68(9):e29073doi: 10.1002/pbc.29073.
Rosabal-Obando, M., Osorio, D. S., Lassaletta, A., La Madrid, A. M., Bartels, U., Finlay, J. L., Qaddoumi, I., Rutkowski, S., & Mynarek, M. (2021). Follow-up evaluation of a web-based pediatric brain tumor board in Latin America. Pediatric blood & cancer, 68(9), e29073. https://doi.org/10.1002/pbc.29073
Rosabal-Obando, Mariel, et al. "Follow-up evaluation of a web-based pediatric brain tumor board in Latin America." Pediatric blood & cancer vol. 68,9 (2021): e29073. doi: https://doi.org/10.1002/pbc.29073
Rosabal-Obando M, Osorio DS, Lassaletta A, La Madrid AM, Bartels U, Finlay JL, Qaddoumi I, Rutkowski S, Mynarek M. Follow-up evaluation of a web-based pediatric brain tumor board in Latin America. Pediatr Blood Cancer. 2021 Sep;68(9):e29073. doi: 10.1002/pbc.29073. Epub 2021 May 18. PMID: 34003601.
Copy Download .nbib Format: NLM
Effect of mouse strain as a background for Alzheimer's disease models on the clearance of amyloid-β.

Journal of systems and integrative neuroscience

Qosa H, Kaddoumi A.
PMID: 27478623
J Syst Integr Neurosci. 2016 Apr;2(2):135-140. doi: 10.15761/JSIN.1000123. Epub 2016 Apr 30.

Novel animal models of Alzheimer's disease (AD) are relentlessly being developed and existing ones are being fine-tuned; however, these models face multiple challenges associated with the complexity of the disease where most of these models do not reproduce the...

Cite
Qosa H, Kaddoumi A. Effect of mouse strain as a background for Alzheimer's disease models on the clearance of amyloid-β. J Syst Integr Neurosci. 2016;2(2):135-140doi: 10.15761/JSIN.1000123.
Qosa, H., & Kaddoumi, A. (2016). Effect of mouse strain as a background for Alzheimer's disease models on the clearance of amyloid-β. Journal of systems and integrative neuroscience, 2(2), 135-140. https://doi.org/10.15761/JSIN.1000123
Qosa, Hisham, and Kaddoumi, Amal. "Effect of mouse strain as a background for Alzheimer's disease models on the clearance of amyloid-β." Journal of systems and integrative neuroscience vol. 2,2 (2016): 135-140. doi: https://doi.org/10.15761/JSIN.1000123
Qosa H, Kaddoumi A. Effect of mouse strain as a background for Alzheimer's disease models on the clearance of amyloid-β. J Syst Integr Neurosci. 2016 Apr;2(2):135-140. doi: 10.15761/JSIN.1000123. Epub 2016 Apr 30. PMID: 27478623; PMCID: PMC4963020.
Copy Download .nbib Format: NLM
Barriers to Care and Outcomes of Pediatric Acute Lymphoblastic Leukemia Treatment in the Gaza Strip.

Journal of pediatric hematology/oncology

Mills D, Abushanab S, Elhaloul A, El Nuweiry H, Shbair M, Qaddoumi I, Salman Z.
PMID: 34705357
J Pediatr Hematol Oncol. 2022 Jan 01;44(1):e123-e126. doi: 10.1097/MPH.0000000000002338.

BACKGROUND: Childhood acute lymphoblastic leukemia (ALL) is the most common pediatric cancer worldwide. Although children in high-income countries enjoy survival rates of ~90%, children in countries with limited resources suffer from survival rates of

Cite
Mills D, Abushanab S, Elhaloul A, et al. Barriers to Care and Outcomes of Pediatric Acute Lymphoblastic Leukemia Treatment in the Gaza Strip. J Pediatr Hematol Oncol. 2022;44(1):e123-e126doi: 10.1097/MPH.0000000000002338.
Mills, D., Abushanab, S., Elhaloul, A., El Nuweiry, H., Shbair, M., Qaddoumi, I., & Salman, Z. (2022). Barriers to Care and Outcomes of Pediatric Acute Lymphoblastic Leukemia Treatment in the Gaza Strip. Journal of pediatric hematology/oncology, 44(1), e123-e126. https://doi.org/10.1097/MPH.0000000000002338
Mills, David, et al. "Barriers to Care and Outcomes of Pediatric Acute Lymphoblastic Leukemia Treatment in the Gaza Strip." Journal of pediatric hematology/oncology vol. 44,1 (2022): e123-e126. doi: https://doi.org/10.1097/MPH.0000000000002338
Mills D, Abushanab S, Elhaloul A, El Nuweiry H, Shbair M, Qaddoumi I, Salman Z. Barriers to Care and Outcomes of Pediatric Acute Lymphoblastic Leukemia Treatment in the Gaza Strip. J Pediatr Hematol Oncol. 2022 Jan 01;44(1):e123-e126. doi: 10.1097/MPH.0000000000002338. PMID: 34705357.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 49 entries